April 17, 2023
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
You might also be interested by
Scientific Publications
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
July 18, 2022
Histopathology
More infoWeb News
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
March 1, 2022
Histopathology
More info